SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-23-030593
Filing Date
2023-03-09
Accepted
2023-03-09 16:17:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 tm238549d3_425.htm 425 136500
2 GRAPHIC tm238549d3_425img001.jpg GRAPHIC 8020
3 GRAPHIC tm238549d3_425img002.jpg GRAPHIC 12025
  Complete submission text file 0001104659-23-030593.txt   166135
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filed by) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Subject) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-38811 | Film No.: 23719972
SIC: 2836 Biological Products, (No Diagnostic Substances)